Bank of America
LPCN icon

Bank of America’s Lipocine LPCN Stock Holding History

Bank of America’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52
Closed -$417 – 6390
2025
Q4 		$417 Buy
52
+3
+6% +$10 ﹤0.01% 6587
2025
Q3 		$139 Sell
49
-2,538
-98% -$7.71K ﹤0.01% 7791
2025
Q2 		$8.18K Buy
2,587
+6
+0.2% +$19 ﹤0.01% 7229
2025
Q1 		$8.21K Buy
2,581
+2,519
+4,063% +$9.75K ﹤0.01% 7147
2024
Q4 		$303 Buy
62
+6
+11% +$30 ﹤0.01% 7503
2024
Q3 		$252 Buy
56
+12
+27% +$60 ﹤0.01% 7519
2024
Q2 		$363 Buy
+44
New +$275 ﹤0.01% 7417
2024
Q1 		– Sell
-6
Closed -$16 – 7998
2023
Q4 		$16 Sell
6
-53
-90% -$140 ﹤0.01% 7691
2023
Q3 		$176 Hold
59
– – ﹤0.01% 7421
2023
Q2 		$297 Hold
59
– – ﹤0.01% 7359
2023
Q1 		$318 Sell
59
-11
-16% -$85 ﹤0.01% 7399
2022
Q4 		$475 Buy
70
+11
+19% +$80 ﹤0.01% 7439
2022
Q3 		$0 Hold
59
– – ﹤0.01% 8037
2022
Q2 		$1K Hold
59
– – ﹤0.01% 7872
2022
Q1 		$1K Sell
59
-10
-14% -$209 ﹤0.01% 8118
2021
Q4 		$1K Sell
69
-58
-46% -$1.08K ﹤0.01% 8069
2021
Q3 		$2K Buy
127
+66
+108% +$1.46K ﹤0.01% 7892
2021
Q2 		$1K Buy
61
+2
+3% +$47 ﹤0.01% 7625
2021
Q1 		$2K Sell
59
-854
-94% -$24.6K ﹤0.01% 7246
2020
Q4 		$21K Buy
913
+854
+1,447% +$20.6K ﹤0.01% 6578
2020
Q3 		$1K Hold
59
– – ﹤0.01% 6775
2020
Q2 		$1K Hold
59
– – ﹤0.01% 6737
2020
Q1 		$0 Hold
59
– – ﹤0.01% 7072
2019
Q4 		$0 Sell
59
-17
-22% -$435 ﹤0.01% 7260
2019
Q3 		$4K Sell
76
-320
-81% -$12.8K ﹤0.01% 6891
2019
Q2 		$13K Buy
396
+337
+571% +$10.4K ﹤0.01% 6662
2019
Q1 		$2K Hold
59
– – ﹤0.01% 6911
2018
Q4 		$1K Sell
59
-40
-40% -$928 ﹤0.01% 6973
2018
Q3 		$2K Buy
99
+27
+38% +$664 ﹤0.01% 7022
2018
Q2 		$2K Buy
72
+13
+22% +$310 ﹤0.01% 6913
2018
Q1 		$2K Hold
59
– – ﹤0.01% 6896
2017
Q4 		$3K Buy
+59
New +$3.67K ﹤0.01% 6813
2017
Q3 		– Sell
-349
Closed -$24K – 7175
2017
Q2 		$24K Buy
349
+29
+9% +$1.89K ﹤0.01% 6166
2017
Q1 		$21K Buy
320
+186
+139% +$12.1K ﹤0.01% 6294
2016
Q4 		$8K Buy
134
+88
+191% +$5.57K ﹤0.01% 6606
2016
Q3 		$4K Buy
46
+28
+156% +$1.74K ﹤0.01% 6677
2016
Q2 		$1K Buy
+18
New +$2.79K ﹤0.01% 6993
2015
Q3 		– Sell
-4,889
Closed -$713K – 7318
2015
Q2 		$713K Buy
+4,889
New +$607K ﹤0.01% 4407

Other funds holding LPCN

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Bank of America's LPCN Position: Q1 2026 in Review

Bank of America sold out of Lipocine (LPCN) in Q1 2026, closing a stake of 52 shares — an estimated $417 sold.

Bank of America first reported a position in LPCN in Q2 2015 and held it in 38 quarters. The position peaked at $713K in Q2 2015. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.

  • Bank of America reported no remaining Lipocine position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 52 Lipocine shares in Q1 2026, an estimated $417.
  • Bank of America first reported a position in Lipocine in Q2 2015 and held it in 38 quarters.
  • Bank of America's Lipocine position peaked at $713K in Q2 2015.
  • 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.